Synedica Retatrutide 40mg  Pen- Triple Agonist Peptide for Weight Loss

Synedica Retatrutide 40mg – is an advanced tri-agonist peptide that targets GLP-1, GIP, and glucagon receptors simultaneously. This powerful compound is designed for research into next-generation weight loss, energy balance, and metabolic optimization,Backed by Synedica’s reputation for pharmaceutical-grade innovation, this 40mg formulation is ideal for studies involving multi-pathway appetite regulation, improved insulin signaling, and fat oxidation. it shows significant potential in reducing body fat and improving insulin sensitivity

Key Features:

• Triple receptor agonist: GLP-1, GIP, and Glucagon
• 40mg per vial – potent and long-acting
• Synedica-grade peptide quality
• Ideal for cutting-edge obesity and diabetes research

How to Use Synedica Retatutide:
Form: Injectable peptide
Dosage: Start with 0.5 mg per week, gradually increase to 3-4 mg per week as tolerated.
Cycle Length: Typically 8–16 weeks; take a 4-week break after each cycle
Administration: Subcutaneous injection, once a week

How It Works:

• GLP-1 Agonism: Reduces appetite and helps control blood sugar levels.
• GIP Agonism: Supports insulin release and boosts metabolic efficiency.
• Glucagon Activation: Increases energy expenditure and fat breakdown.

By targeting these three pathways, Synedica Retatutide offers more effective fat loss and metabolic benefits than traditional peptides like semaglutide or liraglutide.

Recommended Stacks:
Synedica Semaglutide (low dose) for additional appetite control
Viogen Semaglutide or Hyge Semaglutide for post-cycle maintenance
Tirzepatide-based products (like VLS or Synedica Tirzepatide) for a gradual transition after the cycle